Alterations in central and peripheral GC production and sensitivity are common in obese humans and in rodent models of obesity, which contribute to fat accumulation in hepatic cells and increased visceral depots [33, 50] and may cause peripheral insulin resistance [16]. Here, INS is linked to obesity disorder.